University of Minnesota announces clinical trial for opioid vaccine

Drug Discovery & Development | September 7, 2021

The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. Marco Pravetoni, PhD, is leading the drug discovery research and will join the UW Medicine Garvey Institute for Brain Health Solutions in 2022.


Pamela Y. Collins appointed to the National Advisory Mental Health Council

June 30, 2021

Pamela Y. Collins, MD, MPH, who holds a joint professorship in psychiatry and global health, has been appointed to the prestigious National Institute of Mental Health’s National Advisory Mental Health Council (NAMHC).



Re-Imagining Behavioral Health: Race, Equity and Social Justice Conference

Sept 23-24, 2021

Sponsored by the Behavioral Health Institute at Harborview Medical Center, this 2nd annual conference will feature speakers Dr. Caprice Hollins and Senator Joe Nguyen. More information and registration information coming soon.